Abstract
In a randomized, double-blind study, the effects of individualized homœopathy in patients
suffering from proctocolitis were investigated. The study was controlled against conventional
therapy and placebo.
Individually indicated homoœopathic medicines were prescribed in the 30c, 200c or
1,000c potencies.
The researchers did not succeed in attracting sufficient numbers of participants to
arrive at statistically significant conclusions. The total number of patients in the
three combined groups was only 20, which was far below the target figure. The causes
of this are discussed.
Bowel habit and subjective parameters were assessed by a weekly health calendar. This
calendar had not been previously validated. The conventional group scored best: eight
out of ten patients completed the year of research and improved both with regard to
their proctocolitis and their general well-being.
Key Words
Double-blind trial - Homœopathy - Individualization - Proctocolitis - Methodology
- Netherlands